1
|
Li W, Yang Y, Wang J, Ge T, Wan S, Gui L, Tao Y, Song P, Yang L, Ge F, Zhang W. Establishment of bone-targeted nano-platform and the study of its combination with 2-deoxy-d-glucose enhanced photodynamic therapy to inhibit bone metastasis. J Mech Behav Biomed Mater 2024; 150:106306. [PMID: 38091923 DOI: 10.1016/j.jmbbm.2023.106306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Revised: 12/02/2023] [Accepted: 12/03/2023] [Indexed: 01/09/2024]
Abstract
At present, simple anti-tumor drugs are ineffective at targeting bone tissue and are not purposed to treat patients with bone metastasis. In this study, zoledronic acid (ZOL) demonstrated excellent bone-targeting properties as a bone-targeting ligand. The metal-organic framework (MOF) known as ZIF-90 was modified with ZOL to construct a bone-targeting-based drug delivery system. Chlorin e6 (Ce6) was loaded in the bone-targeted drug delivery system and combined with 2-deoxy-D-glucose (2-DG), which successfully treated bone tumors when enhanced photodynamic therapy was applied. The Ce6@ZIF-PEG-ZOL (Ce6@ZPZ) nanoparticles were observed to have uniform morphology, a particle size of approximately 210 nm, and a potential of approximately -30.4 mV. The results of the bone-targeting experiments showed that Ce6@ZPZ exhibited a superior bone-targeted effect when compared to Ce6@ZIF-90-PEG. The Ce6@ZPZ solution was subjected to 660 nm irradiation and the resulting production of reactive oxygen species increased over time, which could be further increased when Ce6@ZPZ was used in combination with 2-DG. Their combination had a stronger inhibitory capacity against tumor cells than either 2-DG or Ce6@ZPZ alone, increasing the rate of tumor cell apoptosis. The apoptosis rate caused by HGC-27 was 61.56% when 2-DG was combined with Ce6@ZPZ. In vivo results also showed that Ce6@ZPZ combined with 2-DG maximally inhibited tumor growth and prolonged mice survival compared to the other experimental groups. Therefore, the combination of PDT and glycolytic inhibitors serves as a potential option for the treatment of cancer.
Collapse
Affiliation(s)
- Wanzhen Li
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui, 241000, People's Republic of China
| | - Yongqi Yang
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui, 241000, People's Republic of China
| | - Jun Wang
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui, 241000, People's Republic of China
| | - Ting Ge
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui, 241000, People's Republic of China
| | - Shuixia Wan
- Soil and Fertilizer Research Institute, Anhui Academy of Agricultural Sciences, Hefei, 230031, People's Republic of China
| | - Lin Gui
- Department of Microbiology and Immunology, Wannan Medical College, Wuhu, Anhui, 241002, People's Republic of China
| | - Yugui Tao
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui, 241000, People's Republic of China
| | - Ping Song
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui, 241000, People's Republic of China.
| | - Liangjun Yang
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui, 241000, People's Republic of China.
| | - Fei Ge
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui, 241000, People's Republic of China.
| | - Weiwei Zhang
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui, 241000, People's Republic of China.
| |
Collapse
|
2
|
Tayebi L, Rahimi R, Akbarzadeh AR, Maleki A. A reliable QSPR model for predicting drug release rate from metal-organic frameworks: a simple and robust drug delivery approach. RSC Adv 2023; 13:24617-24627. [PMID: 37601598 PMCID: PMC10432896 DOI: 10.1039/d3ra00070b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2023] [Accepted: 06/05/2023] [Indexed: 08/22/2023] Open
Abstract
During the drug release process, the drug is transferred from the starting point in the drug delivery system to the surface, and then to the release medium. Metal-organic frameworks (MOFs) potentially have unique features to be utilized as promising carriers for drug delivery, due to their suitable pore size, high surface area, and structural flexibility. The loading and release of various therapeutic drugs through the MOFs are effectively accomplished due to their tunable inorganic clusters and organic ligands. Since the drug release rate percentage (RES%) is a significant concern, a quantitative structure-property relationship (QSPR) method was applied to achieve an accurate model predicting the drug release rate from MOFs. Structure-based descriptors, including the number of nitrogen and oxygen atoms, along with two other adjusted descriptors, were applied for obtaining the best multilinear regression (BMLR) model. Drug release rates from 67 MOFs were applied to provide a precise model. The coefficients of determination (R2) for the training and test sets obtained were both 0.9999. The root mean square error for prediction (RMSEP) of the RES% values for the training and test sets were 0.006 and 0.005, respectively. To examine the precision of the model, external validation was performed through a set of new observations, which demonstrated that the model works to a satisfactory degree.
Collapse
Affiliation(s)
- Leila Tayebi
- Department of Chemistry, Iran University of Science and Technology P. O. Box: 16846-13114 Tehran Islamic Republic of Iran
| | - Rahmatollah Rahimi
- Department of Chemistry, Iran University of Science and Technology P. O. Box: 16846-13114 Tehran Islamic Republic of Iran
| | - Ali Reza Akbarzadeh
- Department of Chemistry, Iran University of Science and Technology P. O. Box: 16846-13114 Tehran Islamic Republic of Iran
| | - Ali Maleki
- Department of Chemistry, Iran University of Science and Technology P. O. Box: 16846-13114 Tehran Islamic Republic of Iran
| |
Collapse
|
3
|
Verkhovskii RA, Ivanov AN, Lengert EV, Tulyakova KA, Shilyagina NY, Ermakov AV. Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy. Pharmaceutics 2023; 15:pharmaceutics15051566. [PMID: 37242807 DOI: 10.3390/pharmaceutics15051566] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Revised: 05/19/2023] [Accepted: 05/20/2023] [Indexed: 05/28/2023] Open
Abstract
The paradigm of drug delivery via particulate formulations is one of the leading ideas that enable overcoming limitations of traditional chemotherapeutic agents. The trend toward more complex multifunctional drug carriers is well-traced in the literature. Nowadays, the prospectiveness of stimuli-responsive systems capable of controlled cargo release in the lesion nidus is widely accepted. Both endogenous and exogenous stimuli are employed for this purpose; however, endogenous pH is the most common trigger. Unfortunately, scientists encounter multiple challenges on the way to the implementation of this idea related to the vehicles' accumulation in off-target tissues, their immunogenicity, the complexity of drug delivery to intracellular targets, and finally, the difficulties in the fabrication of carriers matching all imposed requirements. Here, we discuss fundamental strategies for pH-responsive drug delivery, as well as limitations related to such carriers' application, and reveal the main problems, weaknesses, and reasons for poor clinical results. Moreover, we attempted to formulate the profiles of an "ideal" drug carrier in the frame of different strategies drawing on the example of metal-comprising materials and considered recently published studies through the lens of these profiles. We believe that this approach will facilitate the formulation of the main challenges facing researchers and the identification of the most promising trends in technology development.
Collapse
Affiliation(s)
- Roman A Verkhovskii
- Science Medical Center, Saratov State University, 83 Astrakhanskaya Str., 410012 Saratov, Russia
| | - Alexey N Ivanov
- Central Research Laboratory, Saratov State Medical University of V. I. Razumovsky, Ministry of Health of the Russian Federation, 410012 Saratov, Russia
| | - Ekaterina V Lengert
- Central Research Laboratory, Saratov State Medical University of V. I. Razumovsky, Ministry of Health of the Russian Federation, 410012 Saratov, Russia
- Institute of Molecular Theranostics, I. M. Sechenov First Moscow State Medical University, 8 Trubetskaya Str., 119991 Moscow, Russia
| | - Ksenia A Tulyakova
- Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 23 Gagarin Ave., 603950 Nizhny Novgorod, Russia
| | - Natalia Yu Shilyagina
- Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, 23 Gagarin Ave., 603950 Nizhny Novgorod, Russia
| | - Alexey V Ermakov
- Central Research Laboratory, Saratov State Medical University of V. I. Razumovsky, Ministry of Health of the Russian Federation, 410012 Saratov, Russia
- Institute of Molecular Theranostics, I. M. Sechenov First Moscow State Medical University, 8 Trubetskaya Str., 119991 Moscow, Russia
| |
Collapse
|
4
|
Lei C, Yang X, Huang X, Yu S, Zhu H, Lin W, Mou X. A metal‐organic framework ZJU‐136‐Ce for combined chemotherapy and chemodynamic therapy. Z Anorg Allg Chem 2021. [DOI: 10.1002/zaac.202100343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Chen Lei
- School of Materials Science and Engineering Zhejiang Sci-Tech University Hangzhou 310018 P. R. China
| | - Xue Yang
- Hepatobiliary and Pancreatic Surgery Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province Zhejiang Provincial People's Hospital Affiliated People's Hospital of Hangzhou Medical College Hangzhou 310014 P. R. China
| | - Xiajuan Huang
- School of Materials Science and Engineering Zhejiang Sci-Tech University Hangzhou 310018 P. R. China
| | - Shijiang Yu
- School of Materials Science and Engineering Zhejiang Sci-Tech University Hangzhou 310018 P. R. China
| | - Hongliang Zhu
- School of Materials Science and Engineering Zhejiang Sci-Tech University Hangzhou 310018 P. R. China
| | - Wenxin Lin
- School of Materials Science and Engineering Zhejiang Sci-Tech University Hangzhou 310018 P. R. China
| | - Xiaozhou Mou
- Hepatobiliary and Pancreatic Surgery Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province Zhejiang Provincial People's Hospital Affiliated People's Hospital of Hangzhou Medical College Hangzhou 310014 P. R. China
| |
Collapse
|
5
|
Yang J, Wang H, Liu J, Ding M, Xie X, Yang X, Peng Y, Zhou S, Ouyang R, Miao Y. Recent advances in nanosized metal organic frameworks for drug delivery and tumor therapy. RSC Adv 2021; 11:3241-3263. [PMID: 35424280 PMCID: PMC8694185 DOI: 10.1039/d0ra09878g] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2020] [Accepted: 01/05/2021] [Indexed: 12/11/2022] Open
Abstract
Metal organic-frameworks (MOFs) are novel materials that have attracted increasing attention for applications in a wide range of research, owing to their unique advantages including their small particle size, porous framework structure and high specific surface area. Because of their adjustable size, nanoscale MOFs (nano-MOFs) can be prepared as carriers of biotherapy drugs, thus enabling biotherapeutic applications. Nano-MOFs' metal ion catalytic activity and organic group functional characteristics can be exploited in biological treatments. Furthermore, the applications of nano-MOFs can be broadened by hybridization with other materials to form composites. This review focuses on the preparation and recent advances in nano-MOFs as drug carriers, therapeutic materials and functionalized materials in drug delivery and tumor therapy based on the single/multiple stimulus response of drug release to achieve the targeted therapy, offering a comprehensive reference for drug carrier design. At the end, the current challenges and prospects are discussed to provide significant insight into the design and applications of nano-MOFs in drug delivery and tumor therapy.
Collapse
Affiliation(s)
- Junlei Yang
- Institute of Bismuth Science, University of Shanghai for Science and Technology Shanghai 200093 China
| | - Hui Wang
- Institute of Bismuth Science, University of Shanghai for Science and Technology Shanghai 200093 China
| | - Jinyao Liu
- Institute of Bismuth Science, University of Shanghai for Science and Technology Shanghai 200093 China
| | - Mengkui Ding
- Institute of Bismuth Science, University of Shanghai for Science and Technology Shanghai 200093 China
| | - Xianjin Xie
- Institute of Bismuth Science, University of Shanghai for Science and Technology Shanghai 200093 China
| | - Xiaoyu Yang
- Institute of Bismuth Science, University of Shanghai for Science and Technology Shanghai 200093 China
| | - Yaru Peng
- Institute of Bismuth Science, University of Shanghai for Science and Technology Shanghai 200093 China
| | - Shuang Zhou
- Cancer Institute, Tongji University School of Medicine Shanghai 200092 China
| | - Ruizhuo Ouyang
- Institute of Bismuth Science, University of Shanghai for Science and Technology Shanghai 200093 China
| | - Yuqing Miao
- Institute of Bismuth Science, University of Shanghai for Science and Technology Shanghai 200093 China
| |
Collapse
|
6
|
Wang Y, Yan J, Wen N, Xiong H, Cai S, He Q, Hu Y, Peng D, Liu Z, Liu Y. Metal-organic frameworks for stimuli-responsive drug delivery. Biomaterials 2020; 230:119619. [DOI: 10.1016/j.biomaterials.2019.119619] [Citation(s) in RCA: 220] [Impact Index Per Article: 55.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2019] [Revised: 11/09/2019] [Accepted: 11/10/2019] [Indexed: 01/26/2023]
|
7
|
Liu W, Pan Y, Xiao W, Xu H, Liu D, Ren F, Peng X, Liu J. Recent developments on zinc(ii) metal-organic framework nanocarriers for physiological pH-responsive drug delivery. MEDCHEMCOMM 2019; 10:2038-2051. [PMID: 32206240 PMCID: PMC7069377 DOI: 10.1039/c9md00400a] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2019] [Accepted: 09/29/2019] [Indexed: 12/23/2022]
Abstract
The high storage capacities and excellent biocompatibilities of zinc(ii) metal-organic frameworks (Zn-MOFs) have made them outstanding candidates as drug delivery carriers. Recent studies on the pH-responsive processes based on carrier-drug interactions have proven them to be the most efficient and effective way to control the release profiles of drugs. To satisfy the ever-growing demand in cancer therapy, great efforts are being devoted to the development of methods to precisely control drug release and achieve targeted use of an active substance at the right time and place. In this review article, we discuss the diverse stimuli based on Zn-MOFs carriers that have been achieved upon external activation from single pH-stimulus-responsive or/and multiple pH-stimuli-responsive viewpoints. Also, the perspectives and future challenges in this type of carrier system are discussed.
Collapse
Affiliation(s)
- Weicong Liu
- Guangdong Key Laboratory for Research and Development of Natural Drugs, Dongguan Key Laboratory of Drug Design and Formulation Technology , Key Laboratory of Research and Development of New Medical Materials of Guangdong Medical University and School of Pharmacy , Guangdong Medical University , Dongguan , 523808 , P. R. China . ; ; ; Tel: +86 769 22896560
| | - Ying Pan
- Guangdong Key Laboratory for Research and Development of Natural Drugs, Dongguan Key Laboratory of Drug Design and Formulation Technology , Key Laboratory of Research and Development of New Medical Materials of Guangdong Medical University and School of Pharmacy , Guangdong Medical University , Dongguan , 523808 , P. R. China . ; ; ; Tel: +86 769 22896560
| | - Weiwei Xiao
- Biosafety Level-3 Laboratory , Guangdong Provincial Key Laboratory of Tropical Disease Research , School of Public Health , Southern Medical University , Guangdong , Guangzhou 510515 , China
| | - Hongjia Xu
- Guangdong Key Laboratory for Research and Development of Natural Drugs, Dongguan Key Laboratory of Drug Design and Formulation Technology , Key Laboratory of Research and Development of New Medical Materials of Guangdong Medical University and School of Pharmacy , Guangdong Medical University , Dongguan , 523808 , P. R. China . ; ; ; Tel: +86 769 22896560
| | - Dong Liu
- Shenzhen Huachuang Bio-pharmaceutical Technology Co. Ltd. , Shenzhen 518112 , China .
| | - Fei Ren
- Guangdong Provincial Key Laboratory of New Drug Screening , School of Pharmaceutical Sciences , Southern Medical University , Guangzhou 510515 , China
| | - Xinsheng Peng
- Guangdong Key Laboratory for Research and Development of Natural Drugs, Dongguan Key Laboratory of Drug Design and Formulation Technology , Key Laboratory of Research and Development of New Medical Materials of Guangdong Medical University and School of Pharmacy , Guangdong Medical University , Dongguan , 523808 , P. R. China . ; ; ; Tel: +86 769 22896560
| | - Jianqiang Liu
- Guangdong Key Laboratory for Research and Development of Natural Drugs, Dongguan Key Laboratory of Drug Design and Formulation Technology , Key Laboratory of Research and Development of New Medical Materials of Guangdong Medical University and School of Pharmacy , Guangdong Medical University , Dongguan , 523808 , P. R. China . ; ; ; Tel: +86 769 22896560
| |
Collapse
|
8
|
Chen C, Li H. Synthesis and Crystal Structure of Amino Acid Modified NDI Lanthanide Coordination Complex. Z Anorg Allg Chem 2019. [DOI: 10.1002/zaac.201900009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- Chaoyuan Chen
- Key Laboratory of Cluster Science of Ministry of Education; School of Chemistry and Chemical Engineering; Beijing Institute of Technology; 100081 Beijing P. R. China
| | - Hui Li
- Key Laboratory of Cluster Science of Ministry of Education; School of Chemistry and Chemical Engineering; Beijing Institute of Technology; 100081 Beijing P. R. China
| |
Collapse
|